Punjab-based drugmaker asked to stop manufacturing after samples found to be of non-standard quality Govt
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Stay updated with breaking news from Licensing Authority. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(This story has not been edited by THE WEEK and is auto-generated from a PTI
Punjab-based drugmaker QP Pharmachem Ltd has been directed to halt all manufacturing activity after the World Health Organisation (WHO) issued an alert warning that samples of Guaifenesin syrup it produced were of substandard quality. The Central Drugs Standard Control Organisation, in conjunction with Punjab's state drugs authority, had investigated the manufacturer after reports of the contamination in the Marshall Islands and Federated States of Micronesia.
Minister of state for health Bharati Pravin Pawar, in a written reply in the Lower House of Parliament, said the World Health Organization (WHO) issued a medical product alert for a batch of India-made Guaifenesin syrup in the Marshall Islands and the Federated States of Micronesia
Manufacturers are required to comply with the conditions of Licence granted under the said Act and Rules to manufacture any drugs for sale and distribution in the country, says Mandaviya
The business is set to open its doors in Diglis this weekend.